Friday, October 19, 2007

Revision de la importancia de la survivina en el cancer

No solo para diagnostico y tratamiento, sino para inmunoterapia. Magali tenia la idea de hacer un kit de ELISA para detectar survivina o sus anticuerpos en pacientes. Podria ser interesante

The Universal Character of the Tumor-Associated Antigen Survivin
Several clinical trials targeting survivin with a collection of different approaches from small molecule antagonists to immunotherapy are currently under way. With regard to the latter, spontaneous anti-survivin T-cell reactivity has been described in cancer patients suffering from a huge range of cancers of different origin, e.g., breast and colon cancer, lymphoma, leukemia, and melanoma. Thus, survivin may serve as a universal target antigen for anticancer immunotherapy. Accordingly, down-regulation of survivin as a means of immune escape would severely inflict the survival capacity of tumor cells, which highlights this protein as a prime target candidate for therapeutic vaccinations against cancer. Data from several ongoing phase I/II trials targeting survivin for patients with advanced cancer will provide further information about this idea.
 blog it

No comments: